Page last updated: 2024-12-07

3,6-fluorescein diphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID131824
CHEMBL ID1818143
SCHEMBL ID106708
MeSH IDM0201859

Synonyms (13)

Synonym
spiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one, 3',6'-bis(phosphonooxy)-
134869-03-7
3,6-fdp
3,6-fluorescein diphosphate
(3-oxo-6'-phosphonooxyspiro[2-benzofuran-1,9'-xanthene]-3'-yl) dihydrogen phosphate
CHEMBL1818143
FT-0626451
SCHEMBL106708
fluorescein diphosphate triammonium salt
DTXSID60159003
fluorescein3,6-diphosphate
3-oxo-3h-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl bis(dihydrogen phosphate)
spiro[isobenzofuran-1(3h),9'-[9h]xanthen]-3-one,3',6'-bis(phosphonooxy)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID612841Activity of PTP1B2011Bioorganic & medicinal chemistry letters, Sep-01, Volume: 21, Issue:17
Development of a highly selective fluorescence probe for alkaline phosphatase.
AID612838Activity of alkaline phosphatase at 2 uM measured every 2 mins from up to 30 mins by fluorometric analysis2011Bioorganic & medicinal chemistry letters, Sep-01, Volume: 21, Issue:17
Development of a highly selective fluorescence probe for alkaline phosphatase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.22 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]